Why is Epinephrine Not the Drug of Choice in Cardiogenic Shock?
Esther Vorovich
Through the years, epinephrine has been the drug of choice for patients with cardiogenic shock. However, epinephrine was clinically inferior to norepinephrine in comparison studies because of the negative patient outcomes, which were statistically significant. These effects include type B lactic acidosis, tachycardia, increased myocardial oxygen demand, and arrhythmias.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see
our documentation.